Log in to save to my catalogue

Testosterone treatment and the risk of osteonecrosis: a pharmacovigilance analysis in Vigibase

Testosterone treatment and the risk of osteonecrosis: a pharmacovigilance analysis in Vigibase

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2761181233

Testosterone treatment and the risk of osteonecrosis: a pharmacovigilance analysis in Vigibase

About this item

Full title

Testosterone treatment and the risk of osteonecrosis: a pharmacovigilance analysis in Vigibase

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

European journal of clinical pharmacology, 2023-03, Vol.79 (3), p.383-388

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

Purpose
Recent reports have raised concerns about a potential risk of osteonecrosis associated with testosterone treatment (TT). The aim of this pharmacovigilance study was to assess the risk of reporting osteonecrosis associated with the use of TT compared with use of any other medication.
Methods
We performed a disproportionality analysi...

Alternative Titles

Full title

Testosterone treatment and the risk of osteonecrosis: a pharmacovigilance analysis in Vigibase

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2761181233

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2761181233

Other Identifiers

ISSN

0031-6970

E-ISSN

1432-1041

DOI

10.1007/s00228-022-03440-w

How to access this item